Explainable artificial intelligence (XAI) is becoming essential in precision medicine because doctors need to understand not just what an AI system predicts, but why it makes that prediction. A comprehensive systematic review published on August 25, 2026, analyzed 116 studies on explainable AI for multi-omics integration in precision medicine, revealing both the promise and the persistent barriers to getting these tools into actual clinical practice.

The core problem is straightforward: advanced AI models used in medical diagnosis and treatment planning often function as "black boxes." They can be highly accurate at predicting disease subtypes, identifying biomarkers, or forecasting drug responses, but clinicians have no way to understand the reasoning behind those predictions. In healthcare, that opacity is dangerous. Doctors need to know which genetic markers, protein levels, or metabolic patterns drove the AI's conclusion so they can validate the logic, catch errors, and explain recommendations to patients.

What Makes Explainable AI Different in Medical Settings?

Explainable AI techniques work by revealing which features or data points most influenced a model's decision. In precision medicine, where doctors analyze multiple layers of biological data simultaneously (genomics, transcriptomics, proteomics, metabolomics, and more), this transparency becomes even more critical. The review found that XAI methods like SHAP (SHapley Additive exPlanations), attention mechanisms, and saliency maps enabled interpretable predictions across gene, pathway, and network levels.

These techniques help clinicians understand cross-omics interactions and generate testable biological hypotheses. For example, an attention mechanism might highlight which genes across multiple datasets were most important for predicting cancer subtype, while graph neural networks can leverage known biological pathways to make predictions more interpretable. This bridges the gap between raw computational power and clinical utility.

Where Are Explainable AI Systems Being Used Today?

The review identified explainable AI applications across several high-impact clinical areas. These include cancer subtyping, biomarker discovery, drug response prediction, and prognosis modeling. Despite promising performance in research settings, the researchers found that key challenges persist in moving these systems from the lab to the clinic.

• Data Heterogeneity: Different hospitals and research centers collect and store biological data differently, making it difficult to train AI systems that work reliably across institutions.
• Reproducibility Gaps: Many published studies cannot be replicated by independent teams, raising questions about whether the findings are robust or dependent on specific datasets and conditions.
• Limited Clinical Validation: Few explainable AI systems have been prospectively tested in real clinical workflows with actual patient outcomes tracked over time.
• High Dimensionality and Batch Effects: Multi-omics datasets contain tens of thousands of features, and technical variations between experiments can introduce noise that confuses AI models.

What Do Experts Say About the Path Forward?

The review's authors, from the Department of Artificial Intelligence at Islamia University of Bahawalpur and the Department of Zoology at Cholistan University of Veterinary and Animal Sciences, emphasized that XAI enhances transparency, trust, and biological interpretability in multi-omics models, facilitating their integration into clinical workflows. However, they stressed that emerging directions such as federated learning, causal AI, foundation models, digital twins, and human-in-the-loop systems offer potential solutions to current limitations.

Federated learning, for instance, allows AI models to be trained across multiple hospitals without centralizing sensitive patient data. Causal AI goes beyond correlation to identify cause-and-effect relationships in biological systems. Digital twins create virtual simulations of individual patients that can be used to test treatment options before implementation. Human-in-the-loop systems keep clinicians actively involved in decision-making rather than treating AI as a fully autonomous tool.

How to Implement Explainable AI in Clinical Practice

• Standardized Evaluation Frameworks: Establish consistent methods for testing whether XAI explanations are actually faithful to the model's internal logic and not just plausible-sounding stories.
• Robust Clinical Validation: Conduct prospective studies where explainable AI systems are tested in real clinical workflows with actual patient outcomes tracked to confirm that understanding the AI's reasoning improves clinical decision-making.
• Interdisciplinary Collaboration: Bring together computer scientists, biologists, clinicians, and regulatory experts to design systems that are both technically sound and practically deployable in hospitals.
• Transparency Documentation: Require clear documentation of which datasets were used to train the model, what preprocessing steps were applied, and what limitations or biases might affect predictions.

The review provides a comprehensive roadmap for developing reliable and clinically actionable XAI-driven multi-omics systems, but the authors make clear that the work is far from complete. The translational gap between computational innovation and real-world clinical deployment remains substantial. Standardized evaluation frameworks and robust clinical validation are essential to advance real-world implementation.

Why Does This Matter Beyond the Lab?

The stakes are high. Precision medicine promises to move healthcare away from one-size-fits-all treatments toward interventions tailored to each patient's unique genetic, environmental, and lifestyle factors. This approach could improve diagnostic accuracy, prognostic stratification, and therapeutic efficacy, particularly in oncology. But that promise can only be realized if clinicians trust the AI systems guiding their decisions, and trust requires understanding. Without explainability, even highly accurate AI systems risk being rejected by the medical community or, worse, being blindly followed without appropriate clinical judgment.

The 116 studies reviewed in this analysis show that the technical foundations for explainable AI in precision medicine are being built. The challenge now is ensuring those foundations translate into systems that clinicians can confidently integrate into their daily practice, with full transparency about how the AI reached its conclusions and what limitations might affect its reliability in specific cases.